explore -WSS

explore

author：explore 2025-09-06 01:41:22 - browse：37825

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Feng Zhang CRISPR delivery startup lays off quarter of staff

WSS

Videos point to link between seizures and unexplained toddler deaths

Burning questions for the 2024 JPM Healthcare Conference

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

What causes an itch? Researchers may have solved the mystery

The biotech scorecard for Q1: 17 stock

Leukemia patients are helped by Syndax's new type of therapy

Wikipedia

explore

leisure time

New air purifier tech could be key to improving indoor air quality

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Trump demands the U.S. pay no more for drugs than other countries … again

Why psychiatrists like me stop taking insurance

In Memoriam: Notable people who died in 2023

3 medical device trends to watch in 2024

Jerome Adams on the need for new antivirals for Covid

FDA needs staff influx to meet gene therapy needs, Marks says

Continuity nursing helped my family in our darkest PICU moments

SCOTUS to consider access to abortion pill mifepristone

knowledge

How a scoliosis diagnosis changed the life of one young dancer

Federal weight loss drug coverage is 30 years out of date

Patients' immediate access to test results puts radiologists in a bind

Chronically ill young patients struggle to find fertility info

Leukemia patients are helped by Syndax's new type of therapy

FDA approves world's first CRISPR

focus

hotspot

hotspot

Wikipedia